Mayne Pharma Group Limited (ASX:MYX)
5.28
+0.01 (0.19%)
Sep 5, 2025, 4:10 PM AEST
Mayne Pharma Group Employees
Mayne Pharma Group had 491 employees as of June 30, 2025. The number of employees decreased by 509 or -50.90% compared to the previous year.
Employees
491
Change
-509
Growth
-50.90%
Revenue / Employee
831.15K AUD
Profits / Employee
-191.11K AUD
Market Cap
428.17M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 491 | -509 | -50.90% |
Jun 30, 2019 | 1,000 | 220 | 28.21% |
Jun 30, 2018 | 780 | -9 | -1.14% |
Jun 30, 2017 | 789 | 89 | 12.71% |
Jun 30, 2016 | 700 | 100 | 16.67% |
Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
CSL Limited | 29,904 |
Pro Medicus | 132 |
Cochlear | 5,500 |
Sonic Healthcare | 42,000 |
Ramsay Health Care | 90,000 |
Ansell | 15,000 |
Telix Pharmaceuticals | 234 |
Mesoblast | 73 |
Mayne Pharma Group News
- 4 days ago - Mayne Pharma Group Ltd (MAYNF) Full Year 2025 Earnings Call Highlights: Strong Women's Health ... - GuruFocus
- 4 days ago - Full Year 2025 Mayne Pharma Group Ltd Earnings Call Transcript - GuruFocus
- 7 days ago - Mayne Pharma dodges questions on financial results - The Australian Financial Review
- 7 weeks ago - Jefferies, Mayne Pharma in spotlight in after suitor’s court win - The Australian Financial Review
- 2 months ago - Hedge fund bets US suitor won’t get out of Mayne Pharma takeover - The Australian Financial Review
- 3 months ago - Proxy advisers support Mayne Pharma deal as suitor tries to exit - The Australian Financial Review
- 3 months ago - Cosette terminates $672m Mayne Pharma deal as legal challenge looms - The Australian Financial Review
- 3 months ago - Why a private equity group is rethinking its bid for Mayne Pharma - The Australian Financial Review